ArticlePloS one2024
Transcriptomic analysis of male diamondback moth antennae: Response to female semiochemicals and allyl isothiocyanate.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Female semiochemicals and allyl isothiocyanate (AITC) attract moths, and the moths use odorant-degrading enzymes (ODEs) to break down the excess odor. By identifying antennae-specific ODEs, researchers have established the molecular foundation for odorant degradation and signal inactivation in insects. This enables further exploration of new pest control methods. Currently, the degradation of female semiochemicals and AITC has received limited attention, inspiring this study to identify target ODEs in diamondback moths through transcriptome analysis. Sequencing of antennae from male adults (MA) exposed to female adults (FA) and AITC yielded a substantial 54.18 Gb of clean data, revealing 2276 differentially expressed genes (DEGs) between the MA and MA-FA treatments, and 629 DEGs between MA and MA-AITC treatments. The analysis of MAs exposed to FAs and AITC identified 29 and 17 ODEs, respectively, mainly involving aldehyde dehydrogenases (ALDHs), alcohol dehydrogenases (ADs), cytochrome P450s (CYPs), and UDP-glucuronosyltransferases (UGTs). Pathway analysis revealed primary enrichment in glycolysis/gluconeogenesis and fatty acid degradation in female adult treatments. In contrast, AITC treatments showed major enrichment in pathways related to pentose and glucuronate interconversions, retinol metabolism, and ascorbate and aldarate metabolism. Additionally, qRT-PCR analysis validated the expression patterns of 10 ODE genes in response to these treatments, with varying results observed among the genes. These findings indicate significant changes in ODE expression levels, providing a molecular foundation for identifying potential targets for behavioral inhibitors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.